CLINICAL_TRIALS
trial_result
· 2023-02-03
Clinical Trial Update: A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies [Phase 1, Phase 2]
Summary
A phase 1/2 clinical trial evaluating BBI608 in combination with paclitaxel in adult patients with advanced cancers has completed enrollment with results posted…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-02-03